Cas:146651-71-0 tert-butyl N-[1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl]carbamate manufacturer & supplier

Chemical Name:tert-butyl N-[1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl]carbamate

CAS.NO:146651-71-0

Synonyms:N-Boc tris(hydroxymethyl)aminomethane;tert-butyl (1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl)carbamate;N-(tert-butyloxycarbonyl)-1,1,1-tris(hydroxymethyl)methylamine;tert-Butyl N-tris(hydroxymethyl)methylcarbamate;N-(tert-butyloxycarbonyl)-2-amino-2-(hydroxymethyl)propane-1,3-diol;N-(tert-butyloxycarbonyl)tris(hydroxymethyl)aminomethane;tert-butyl N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]carbamate

Molecular Formula:C₉H₁₉NO₅

Molecular Weight:221.25100

HS Code:2924199090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:99.02000

Exact Mass:221.12600

LogP:

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like N-Boc tris(hydroxymethyl)aminomethane chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,tert-butyl N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]carbamate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N-(tert-butyloxycarbonyl)tris(hydroxymethyl)aminomethane Use and application,N-Boc tris(hydroxymethyl)aminomethane technical grade,usp/ep/jp grade.

Related News: At present, Teva can produce more than 300 generic drugs, and the API department has approximately 650 authorized patents and patent applications worldwide. It is also the generic drug company with the most challenges in patenting ParagraphIV in the world. tert-butyl N-[1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl]carbamate manufacturer The outlook for a cure is clouded with theoretical uncertainties and high-profile failures. Pharmaceutical giants including Johnson & Johnson, Merck and Pfizer have ditched their projects on unsatisfactory data. tert-butyl N-[1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl]carbamate supplier Russia, which shares a 2,600-mile border with China, reported its first two coronavirus cases on Friday. tert-butyl N-[1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl]carbamate vendor The outlook for a cure is clouded with theoretical uncertainties and high-profile failures. Pharmaceutical giants including Johnson & Johnson, Merck and Pfizer have ditched their projects on unsatisfactory data. tert-butyl N-[1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl]carbamate factory Commonly used generic drugs: the products whose patents have expired and the generic drugs of many companies have participated in the competition, and the market demand is large.